HB 4352 – Michigan

Status: Enacted
Year Introduced: 2021
Year Enacted: 2022
Link: http://www.legislature.mi.gov/(S(qdkkcwy1jedqn1yhcgmzqbkr))/mileg.aspx?page=getobject&objectname=2021-HB-4352&query=on

House Bill 4352 would amend the Public Health Code. Currently under the code, if a pharmacist who sells drugs at retail is asked, he or she must provide the current selling price of a drug the pharmacy dispenses or comparative current selling prices of generic and brand name drugs it dispenses. This information must be given before a drug is dispensed. Asking for this information does not oblige a person to buy a drug asked about. The bill would retain these provisions, but would amend them to allow a pharmacist to provide this information without first being asked. Further, the bill would prohibit a pharmacy or pharmacist from entering into a contract prohibiting the disclosure of this information. The bill would also amend the comparative selling prices the pharmacist must now disclose upon request (and under the bill could volunteer) to include biosimilar drug products.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found